نتایج جستجو برای: regadenoson
تعداد نتایج: 274 فیلتر نتایج به سال:
et al. Adenosine versus regadenosoncomparative evaluation inmyocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007;14:645–58. 17. Mahmarian JJ, Cerqueira MD, Iskandrian AE, Bateman TM, Thomas GS, Hendel RC et al. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis fromthe ADVANCE MPI 2...
Background Cardiac stress MR perfusion imaging requires an MRI compatible infusion pump for the administration of adenosine or a non-MRI compatible pump housed in the control room or beyond the 10-Gauss line. Regadenoson is a recently FDA-approved A2A receptor agonist that can be given intravenously in a single bolus. It has been shown to provide diagnostic information regarding myocardial isch...
Background Long-term survival after orthotopic heart transplant (OHT) is limited by coronary allograft vasculopathy and its associated myocardial perfusion abnormalities. Little is known how post-OHT patients respond to vasodilator stress cardiovascular magnetic resonance imaging (vsCMR). This study aimed (1) to evaluate the safety and hemodynamic response of post-OHT patients undergoing vsCMR ...
The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications. Herein we describe adenosine A2A receptor distribution, signaling pathways, pharmacology, and molecular structure, followed by a summary and SAR discussion of the most relevant series of adenosine A...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید